Antisense modulation of C-reactive protein expression

Details for Australian Patent Application No. 2009200252 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Graham, Mark J.; Crooke, Rosanne M.

Agent Davies Collison Cave

Pub. Number AU-B-2009200252

Parent 2002313682

Filing date 23 January 2009

Wipo publication date 12 February 2009

Acceptance publication date 7 April 2011

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

12 February 2009 Application Open to Public Inspection

  Published as AU-B-2009200252

12 February 2009 Complete Application Filed

7 April 2011 Application Accepted

  Published as AU-B-2009200252

4 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009200253-Commercial Airline Flight Planning System

2009200251-Wideband antenna pattern